M28 Capital Management LP Long-Term Concentrated

Location: Stamford, CT

CIK: 0001807489 · Show all filings

Period: Q4 2025 (← Previous) (Next →)

Filing Date: Feb 13, 2026

Total Value: $138M (100.0% shares, 0.0% debt)

Holdings (9)

WVE WAVE LIFE SCIENCES LTD 70.0%

Value $96.3M Shares 5,664,548 Est. Cost $3.40 Unrealized +199.0%

IVVD INVIVYD INC 16.6%

Value $22.84M Shares 9,248,250 Est. Cost $17.64 Unrealized -88.2%

TGTX TG THERAPEUTICS INC 3.5%

Value $4.817M Shares 161,600 Est. Cost $15.49 Unrealized +110.8%

ARWR ARROWHEAD PHARMACEUTICALS IN 3.3%

Value $4.475M Shares 67,400 Est. Cost $33.13 Unrealized +47.9%

GUTS FRACTYL HEALTH INC 3.0%

Value $4.083M Shares 1,856,117 Est. Cost $8.42 Unrealized -80.9%

PRQR PROQR THRAPEUTICS N V 1.5%

Value $2.059M Shares 1,019,498 Est. Cost $2.38 Unrealized -1.8%

RCKT ROCKET PHARMACEUTICALS INC 1.0%

Value $1.354M Shares 385,680 Est. Cost $23.75 Unrealized -85.6%

SLN SILENCE THERAPEUTICS PLC 0.8%

Value $1.125M Shares 185,100 Est. Cost $9.41 Unrealized —

CRIS CURIS INC 0.4%

Value $514K Shares 521,059 Est. Cost $11.24 Unrealized -88.1%

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
WVE	WAVE LIFE SCIENCES LTD	5,664,548	$96.3M	70.0%	$3.40	+199.0%	SHS	Y95308105
IVVD	INVIVYD INC	9,248,250	$22.84M	16.6%	$17.64	-88.2%	COM	00534A102
TGTX	TG THERAPEUTICS INC	161,600	$4.817M	3.5%	$15.49	+110.8%	COM	88322Q108
ARWR	ARROWHEAD PHARMACEUTICALS IN	67,400	$4.475M	3.3%	$33.13	+47.9%	COM	04280A100
GUTS	FRACTYL HEALTH INC	1,856,117	$4.083M	3.0%	$8.42	-80.9%	COM	35168W103
PRQR	PROQR THRAPEUTICS N V	1,019,498	$2.059M	1.5%	$2.38	-1.8%	SHS EURO	N71542109
RCKT	ROCKET PHARMACEUTICALS INC	385,680	$1.354M	1.0%	$23.75	-85.6%	COM	77313F106
SLN	SILENCE THERAPEUTICS PLC	185,100	$1.125M	0.8%	$9.41	—	ADS	82686Q101
CRIS	CURIS INC	521,059	$514K	0.4%	$11.24	-88.1%	COM	231269309